Bottom line
How much do RAGHX and SCHLX overlap?
52% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 57.6% of RAGHX's assets and 46.4% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
SCHLX holds far more positions (65 vs 24), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings RAGHX and SCHLX have in common
| Holding | % of RAGHX | % of SCHLX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 14.84% | 13.85% | 13.85% |
| Abbvie Inc ABBV | 5.52% | 4.90% | 4.90% |
| Vertex Pharmaceuticals Inc VRTX | 5.32% | 2.45% | 2.45% |
| Merck & Company Inc MRK | 5.06% | 4.85% | 4.85% |
| Unitedhealth Group Inc UNH | 4.65% | 5.73% | 4.65% |
| Mckesson Corp MCK | 4.57% | 2.05% | 2.05% |
| Intuitive Surgical Inc ISRG | 3.89% | 2.69% | 2.69% |
| Amgen Inc AMGN | 3.85% | 2.88% | 2.88% |
| Thermo Fisher Scientific Inc TMO | 3.65% | 3.46% | 3.46% |
| Danaher Corp DHR | 3.37% | 2.13% | 2.13% |
| Regeneron Pharmaceuticals Inc REGN | 2.90% | 1.43% | 1.43% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in RAGHX
- West Pharmaceutical Services Inc — 5.92%
- Mettler-toledo International Inc — 3.99%
- Cooper Companies Inc (the) — 3.81%
- Idexx Laboratories Inc — 3.77%
- Lumexa Imaging Holdings Inc — 3.60%
- Healthequity Inc — 3.47%
- Dexcom Inc — 3.05%
- Align Technology Inc — 2.88%
- Steris Plc — 2.32%
- U.s. Physical Therapy Inc — 2.30%
- Globus Medical Inc — 2.21%
- Medline Inc — 1.88%
- Prestige Consumer Healthcare Inc — 1.65%
Only in SCHLX
- Johnson & Johnson — 6.19%
- AstraZeneca PLC — 3.80%
- Novartis AG — 2.90%
- Gilead Sciences Inc — 2.78%
- Stryker Corp — 2.61%
- Abbott Laboratories — 2.39%
- Boston Scientific Corp — 2.10%
- Novo Nordisk A/S — 1.73%
- Medtronic PLC — 1.54%
- Bristol-Myers Squibb Co — 1.50%
- Cardinal Health Inc — 1.34%
- Cencora Inc — 1.26%
- Roche Holding AG — 1.24%
- Pfizer Inc — 1.17%
Asset mix
| Asset type | RAGHX | SCHLX |
|---|---|---|
| Stocks | 98.5% | 99.6% |
| Cash & short-term funds | — | 0.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | RAGHX | SCHLX |
|---|---|---|
| US | 96.2% | 85.7% |
| CH | — | 5.2% |
| GB | — | 3.8% |
| IE | 2.3% | 1.5% |
| DK | — | 1.7% |
| FR | — | 1.0% |
| NL | — | 1.0% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do RAGHX and SCHLX overlap?
What stocks do RAGHX and SCHLX have in common?
Should I own both RAGHX and SCHLX?
Which holds more stocks, RAGHX or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.